Cytotoxicity and in vivo tissue compatibility of poly(amidoamine) with pendant aminobutyl group as a gene delivery vector

Biomaterials

Volumn 31, Issue 16, 2010, Pages 4467-4476

  Peng, Lin ^a   Gao, Yuan ^b   Xue, Ya Nan ^a   Huang, Shi Wen ^a   Zhuo, Ren Xi ^a  

^a WUHAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Biocompatibility; Bone marrow stromal cell; Cytotoxicity; Gene delivery; Poly(amidoamine)

Indexed keywords

APOPTOSIS; BONE MARROW STROMAL CELL; BONE MARROW STROMAL CELLS; GENE DELIVERY; POLY(AMIDO AMINE);

BIOCOMPATIBILITY; BONE; CELL DEATH; CELL MEMBRANES; CYTOTOXICITY; GENE TRANSFER; MORPHOLOGY; NUCLEIC ACIDS;

GENE THERAPY;

ALKYL GROUP; AMINOBUTYL DERIVATIVE; POLYAMIDOAMINE; POLYETHYLENEIMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BONE MARROW CELL; CELL DAMAGE; CELL STRUCTURE; CELL VIABILITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SAFETY; FEMALE; GENE DELIVERY SYSTEM; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; HISTOCOMPATIBILITY; IN VITRO STUDY; LIVER CELL; LIVER PARENCHYMA; MOUSE; MYOSITIS; NECROSIS; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; RAT; STROMA CELL;

ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS, INTRAMUSCULAR; LIVER; MATERIALS TESTING; MICE; MOLECULAR STRUCTURE; POLYAMINES; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; TRANSFECTION;

PAA;

EID: 77950083410     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.02.031     Document Type: Article

References (37)

1. Masago K., Itaka K., Nishiyama N., Chung U.I., Kataoka K. Gene delivery with biocompatible cationic polymer: pharmacogenomic analysis on cell bioactivity. Biomaterials 2007, 28:5169-5175.
2. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003, 4:346-358.
3. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem Rev 2009, 109:259-302.
4. Huh S.H., Do H.J., Lim H.Y., Kim D.K., Choi S.J., Song H., et al. Optimization of 25 kDa linear polyethylenimine for efficient gene delivery. Biologicals 2007, 35:165-171.
5. Kim S.W., Ogawa T., Tabata Y., Nishimura I. Efficacy and cytotoxicity of cationic-agent-mediated nonviral gene transfer into osteoblasts. J Biomed Mater Res A 2004, 71:308-315.
6. Morille M., Passirani C., Vonarbourg A., Clavreul A., Benoit J.P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008, 29:3477-3496.
7. Fischer D., Li Y., Ahlemeyer B., Krieglstein J., Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003, 24:1121-1131.
8. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
9. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330.
10. Jones R.A., Poniris M.H., Wilson M.R. pDMAEMA is internalised by endocytosis but does not physically disrupt endosomes. J Control Release 2004, 96:379-391.
11. Hunter A.C. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev 2006, 58:1523-1531.
12. Putnam D., Gentry C.A., Pack D.W., Langer R. Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci U S A 2001, 98:1200-1205.
13. Lv H., Zhang S., Wang B., Cui S., Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 2006, 114:100-109.
14. Chen J., Xia X.M., Huang S.W., Zhuo R.X. A cleavable-polycation template method for the fabrication of noncrosslinked, porous polyelectrolyte multilayered films. Adv Mater 2007, 19:979-983.
15. Liu M., Chen J., Cheng Y.P., Xue Y.N., Zhuo R.X., Huang S.W. Novel poly (amidoamine)s with pendant primary amines as highly efficient gene delivery vectors. Macromol Biosci 2010, 10. 10.1002/mabi.200900265.
16. Peng L., Liu M., Xue Y.N., Huang S.W., Zhuo R.X. Transfection and intracellular trafficking characteristics for poly(amidoamine)s with pendant primary amine in the delivery of plasmid DNA to bone marrow stromal cells. Biomaterials 2009, 30(29):5825-5833.
17. Marolt D., Augst A., Freed L.E., Vepari C., Fajardo R., Patel N., et al. Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors. Biomaterials 2006, 27:6138-6149.
18. Babister J.C., Tare R.S., Green D.W., Inglis S., Mann S., Oreffo R.O. Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using " bead-in-bead" polysaccharide capsules. Biomaterials 2008, 29:58-65.
19. Valarmathi M.T., Davis J.M., Yost M.J., Goodwin R.L., Potts J.D. A three-dimensional model of vasculogenesis. Biomaterials 2009, 30:1098-1112.
20. Nandoe Tewarie R.D., Hurtado A., Levi A.D., Grotenhuis J.A., Oudega M. Bone marrow stromal cells for repair of the spinal cord: towards clinical application. Cell Transplant 2006, 15:563-577.
21. Kanduc D., Mittelman A., Serpico R., Sinigaglia E., Sinha A.A., Natale C., et al. Cell death: apoptosis versus necrosis (review). Int J Oncol 2002, 21:165-170.
22. Edinger A.L., Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004, 16(6):663-669.
23. Moghimi S.M., Symonds P., Murray J.C., Hunter A.C., Debska G., Szewczyk A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 2005, 11:990-995.
24. Walker J.A., Quirke P. Viewing apoptosis through a 'TUNEL'. J Pathol 2001, 195:275-276.
25. Huerta S., Goulet E.J., Huerta-Yepez S., Livingston E.H. Screening and detection of apoptosis. J Surg Res 2007, 139:143-156.
26. van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998, 31:1-9.
27. Lee G., Schaffer D. Engineering the surface properties of synthetic gene delivery vectors. Somat Cell Mol Genet 2002, 27:17-25.
28. Schiffelers R.M., de Wolf H.K., van Rooy I., Storm G. Synthetic delivery systems for intravenous administration of nucleic acids. Nanomed 2007, 2:169-181.
29. Braun S. Muscular gene transfer using nonviral vectors. Curr Gene Ther 2008, 8:391-405.
30. Lu Q.L., Bou-Gharios G., Partridge T.A. Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther 2003, 10:131-142.
31. Huang S.W., Wang J., Zhang P.C., Mao H.Q., Zhuo R.X., Leong K.W. Water-soluble and nonionic polyphosphoester: synthesis, degradation, biocompatibility and enhancement of gene expression in mouse muscle. Biomacromolecules 2004, 5:306-311.
32. Nishikawa M., Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001, 12:861-870.
33. Gaur U., Sahoo S.K., De T.K., Ghosh P.C., Maitra A., Ghosh P.K. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 2000, 202:1-10.
34. Mahato R.I., Kawabata K., Nomura T., Takakura Y., Hashida M. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J Pharm Sci 1995, 84:1267-1271.
35. Loisel S., Le Gall C., Doucet L., Ferec C., Floch V. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther 2001, 12:685-696.
36. Xiong M.P., Laird Forrest M., Ton G., Zhao A., Davies N.M., Kwon G.S. Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery. Biomaterials 2007, 28:4889-4900.
37. Hwang S.J., Davis M.E. Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration. Curr Opin Mol Ther 2001, 3:183-191.